<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The inhibiting activity of bone marrow fibroblasts and their ability to sustain survival of granulocytic cell precursors have been studied in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo>, <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Fibroblast conditioned medium inhibits proliferation of granulomonocytic precursors stimulated by leucocyte feeder layer or leucocyte conditioned medium </plain></SENT>
<SENT sid="2" pm="."><plain>The effect depends both on the presence of monocytes and the specificity of the disease </plain></SENT>
<SENT sid="3" pm="."><plain>The inhibitory effect is related with long-ranged factors </plain></SENT>
<SENT sid="4" pm="."><plain>Bone marrow fibroblasts are able to sustain survival of hemopoietic precursors via humoral and cell-cell mechanisms </plain></SENT>
<SENT sid="5" pm="."><plain>The regulatory role of bone marrow fibroblasts in <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hemopoietic disorders</z:e> is discussed </plain></SENT>
</text></document>